Page last updated: 2024-10-29

1-methyl-3-isobutylxanthine and Teratocarcinoma

1-methyl-3-isobutylxanthine has been researched along with Teratocarcinoma in 1 studies

1-Methyl-3-isobutylxanthine: A potent cyclic nucleotide phosphodiesterase inhibitor; due to this action, the compound increases cyclic AMP and cyclic GMP in tissue and thereby activates CYCLIC NUCLEOTIDE-REGULATED PROTEIN KINASES
3-isobutyl-1-methylxanthine : An oxopurine that is xanthine which is substituted at positions 1 and 3 by methyl and isobutyl groups, respectively.

Teratocarcinoma: A malignant neoplasm consisting of elements of teratoma with those of embryonal carcinoma or choriocarcinoma, or both. It occurs most often in the testis. (Dorland, 27th ed)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Tegenge, MA1
Stern, M1
Bicker, G1

Other Studies

1 other study available for 1-methyl-3-isobutylxanthine and Teratocarcinoma

ArticleYear
Nitric oxide and cyclic nucleotide signal transduction modulates synaptic vesicle turnover in human model neurons.
    Journal of neurochemistry, 2009, Volume: 111, Issue:6

    Topics: 1-Methyl-3-isobutylxanthine; 8-Bromo Cyclic Adenosine Monophosphate; Cell Differentiation; Cell Line

2009